R&D Supercharging clinical development with RWE – with Recursion... Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
R&D Sponsored Webinar recap: The future of cell and gene therapy in rare d... For decades, treatment options for rare diseases have been limited, often focusing on symptom management rather than addressing the root cause of them
R&D Sponsored Obesity and the endoscopy space: Innovative, minimally invas... According to the World Health Organization (WHO), in 2022, 2.5 billion adults aged 18 years and older were overweight, including over 890 million adults who were living with
R&D Changing Faces - Pharma and Biotech Hires - March 2025 Once again, March saw a variety of biotech leadership hires on both the business and science sides of the industry.
R&D Sponsored Type 1 diabetes: The importance of early screening and diagn... This article was organised, funded, and reviewed by Sanofi.
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
